SCHEMBL1723402

SCHEMBL1723402

CCC(NC(=O)c1c(CN2CCN(C(=O)OCc3ccccc3)CC2)n(-c2ccccc2)c(=O)c2ccccc12)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 13/20 0.43
TACR2 P21452 8/20 0.43
OPRM1 P35372 5/20 0.43
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TACR1 P25103 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.38
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1717901 1.00 TACR3 (0.43) TACR3TACR2OPRM1TSHRNPSR1
SCHEMBL1716895 0.93 TACR3 (0.45) TACR3TACR2OPRM1TSHRNPSR1
SCHEMBL1717859 0.89 TACR3 (0.48) TACR3TACR2OPRM1TSHRNPSR1
SCHEMBL1719117 0.89 TACR3 (0.42) TACR3TACR2OPRM1TSHRNPSR1
SCHEMBL1717680 0.88 TACR3 (0.43) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1717435 0.87 TACR3 (0.47) TACR3TACR2OPRM1TSHRHIF1A
SCHEMBL1718231 0.86 TACR3 (0.49) TACR3TACR2OPRM1TSHRNPSR1
SCHEMBL1717452 0.86 TACR3 (0.46) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1717085 0.86 TACR3 (0.49) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1717555 0.85 TACR3 (0.48) TACR3TACR2OPRM1TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150534-B1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS LUNDBECK & CO AS H (DK) 2012-01-11 EP disclosed